Financial Performance - Q4 2025 net sales reached $468.5 million, a 6% increase from $444.1 million in Q4 2024, driven by acquisitions contributing 6% and favorable foreign currency translation of 2%[4] - Q4 2025 net income was $20.7 million, or $1.18 per diluted share, compared to $14.2 million or $0.81 per diluted share in Q4 2024, reflecting a year-over-year increase of 46% in net income[5] - Full year 2025 net sales totaled $1.89 billion, with a net loss of $2.5 million, including an $88.8 million impairment charge and $35.1 million in restructuring charges[6] - Full year non-GAAP net income was $123.2 million, with non-GAAP earnings per diluted share at $7.02, reflecting a decrease from $7.44 in the previous year[6] - Adjusted EBITDA for Q4 2025 was $71.9 million, an 11% increase from $64.8 million in Q4 2024, primarily due to higher net sales and improved operating margins[5] - Operating income for the full year 2025 was $53.0 million, down from $194.7 million in 2024, indicating a significant decline[32] - Net income attributable to Quaker Chemical Corporation for Q4 2025 was $20.7 million, up from $14.2 million in Q4 2024[32] - Non-GAAP net income for Q4 2025 was $28,857 thousand, compared to $23,570 thousand in Q4 2024, reflecting a strong performance in profitability[22] Cash Flow and Debt - The Company generated $136.5 million in operating cash flow for 2025, down from $204.6 million in 2024, primarily due to lower operating performance and increased cash outflows from restructuring[14] - As of December 31, 2025, total gross debt was $871.2 million, with cash and cash equivalents of $179.8 million, resulting in net debt of $691.4 million, equating to a net debt to trailing twelve months adjusted EBITDA ratio of approximately 2.3x[15] - Cash and cash equivalents decreased to $179.8 million in 2025 from $188.9 million in 2024, reflecting a liquidity contraction[34] - Net cash provided by operating activities decreased to $136,453 million in 2025 from $204,578 million in 2024[37] - Net cash used in investing activities increased to $214,119 million in 2025, compared to $76,420 million in 2024, primarily due to payments related to acquisitions[37] - Net cash provided by financing activities was $61,833 million in 2025, a recovery from a net cash used of $122,664 million in 2024[38] Segment Performance - The Asia/Pacific segment saw a 15% increase in net sales in Q4 2025 compared to Q4 2024, driven by new business wins, while the Americas segment remained flat[10] - Segment operating earnings for the Americas in Q4 2025 were $51,218 thousand, slightly up from $50,930 thousand in Q4 2024, while EMEA and Asia/Pacific segments also showed growth[27] Strategic Initiatives - The Company completed three strategic acquisitions in 2025, contributing positively to revenue growth[6] - Future outlook includes continued focus on strategic planning and potential acquisitions to drive growth and enhance market position[21] Impairment and Charges - The company reported a total impairment charge of $88,840 thousand for the year 2025, impacting overall profitability[27] - Restructuring and related charges rose to $35,130 million in 2025, compared to $6,530 million in 2024[37] - Impairment charges amounted to $88,840 million in 2025, indicating potential asset write-downs[37] Market Outlook - Looking ahead to 2026, the Company anticipates stable end markets in the first half, with potential growth in the latter half, supported by a disciplined focus on operations and cost control[8] Other Financial Metrics - Non-GAAP gross profit for Q4 2025 was $165,524 thousand, up from $156,200 thousand in Q4 2024, resulting in a non-GAAP gross margin of 35.3% compared to 35.2% in the previous year[21] - Non-GAAP operating income for Q4 2025 increased to $45,109 thousand from $40,453 thousand in Q4 2024, with a non-GAAP operating margin of 9.6% versus 9.1%[21] - Adjusted EBITDA for Q4 2025 was $71,861 thousand, an increase from $64,783 thousand in Q4 2024, leading to an adjusted EBITDA margin of 15.3% compared to 14.6%[22] - Total assets increased to $2.8 billion in 2025 from $2.6 billion in 2024, showing a growth of approximately 7.2%[34] - Long-term debt rose to $834.9 million in 2025, up from $669.6 million in 2024, indicating increased leverage[35] - Interest expense for Q4 2025 was $10,783 thousand, compared to $9,077 thousand in Q4 2024, indicating increased borrowing costs[27] - The effect of foreign exchange rate changes on cash resulted in a positive impact of $6,782 million in 2025, contrasting with a negative impact of $11,141 million in 2024[38] Shareholder Information - The basic weighted average common shares outstanding decreased to 17.3 million in Q4 2025 from 17.7 million in Q4 2024[32] - GAAP earnings per diluted share for Q4 2025 were $1.18, up from $0.81 in Q4 2024, while non-GAAP earnings per diluted share increased to $1.65 from $1.33[23] Company Overview - Quaker Houghton operates in over 25 countries, serving thousands of customers in various industries including steel, automotive, and aerospace[30]

Core Insights - Quaker Houghton reported a fourth quarter adjusted EBITDA of $71.9 million, an 11% increase year-over-year, and a full year adjusted EBITDA of $299.2 million [1][2] - The company generated $136.5 million in operating cash flow for the year 2025 and returned $75.9 million to shareholders through dividends and share repurchases [1][2] - Full year net sales reached $1.89 billion, with a net loss of $2.5 million attributed to an $88.8 million impairment charge and $35.1 million in restructuring charges [1][2] Financial Performance - Q4 2025 net sales were $468.5 million, a 6% increase from $444.1 million in Q4 2024, driven by acquisitions and favorable foreign currency translation [1][2] - Q4 2025 non-GAAP net income was $28.9 million, or $1.65 per diluted share, reflecting a 24% increase year-over-year [1][2] - Full year non-GAAP net income was $123.2 million, with non-GAAP earnings per diluted share of $7.02 [1][2] Segment Performance - In Q4 2025, net sales in the Americas segment were $207.8 million, consistent with the previous year, while EMEA and Asia/Pacific segments saw increases of 7% and 15%, respectively [4][5] - The Americas segment experienced a decline in organic sales volumes, while the Asia/Pacific segment benefited from new business wins [2][4] - Segment operating earnings increased across all segments in Q4 2025, primarily due to higher net sales and improved operating margins in EMEA and Americas [2][4] Cash Flow and Liquidity - The company reported a decrease in operating cash flow to $136.5 million in 2025 from $204.6 million in 2024, attributed to lower operating performance and higher cash outflows from restructuring [2][3] - As of December 31, 2025, total gross debt was $871.2 million, with cash and cash equivalents at $179.8 million, resulting in net debt of $691.4 million [2][3] - The company repurchased 364,797 shares for approximately $41.5 million in 2025 [2][3]

Core Viewpoint - Quaker Chemical (KWR) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the actual results being crucial for its near-term stock price movement [1][2]. Earnings Expectations - The upcoming earnings report is expected to reveal quarterly earnings of $1.71 per share, reflecting a year-over-year increase of +28.6% [3]. - Revenues are projected to reach $465.29 million, which is a 4.8% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 2.16% over the last 30 days, indicating a reassessment by analysts regarding the company's earnings outlook [4]. - The Most Accurate Estimate for Quaker Chemical is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -4.54%, suggesting a bearish sentiment among analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, with positive readings being more reliable [9][10]. - Quaker Chemical currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Quaker Chemical exceeded the expected earnings of $1.94 per share by delivering $2.08, resulting in a surprise of +7.22% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [14]. Conclusion - Quaker Chemical does not appear to be a strong candidate for an earnings beat based on current estimates and rankings, but investors should consider other factors before making investment decisions [17].

Core Viewpoint - Quaker Houghton is set to release its fourth quarter and full year 2025 earnings on February 23, 2026, after market close, followed by an investor call on February 24, 2026, at 8:00 a.m. (ET) [1][2] Company Information - Quaker Houghton is the global leader in industrial process fluids, operating in over 25 countries and serving thousands of advanced and specialized companies in sectors such as steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking [3] - The company employs approximately 4,400 individuals, including chemists, engineers, and industry experts, focusing on improving customer operations through innovative and sustainable solutions [3] - Quaker Houghton is headquartered in Conshohocken, Pennsylvania, near Philadelphia, and emphasizes its commitment to best-in-class technology and customized services [3]

Core Viewpoint - RBC Capital has raised the price target for Quaker Houghton (KWR) to $190 from $171 while maintaining an Outperform rating, indicating positive expectations for the company's performance in the specialty chemicals sector [1] Group 1: Price Target and Rating - The price target for Quaker Houghton has been increased to $190 from $171 [1] - RBC Capital maintains an Outperform rating on Quaker Houghton shares [1] Group 2: Q4 Expectations and Future Outlook - The firm anticipates in-line performance for Q4 [1] - Analysts expect company-specific factors to drive improvements in 2026 [1]

Core Insights - The article compares Quaker Chemical (KWR) and Linde (LIN) to determine which stock is more attractive to value investors [1] Group 1: Zacks Rank and Earnings Outlook - Quaker Chemical has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while Linde has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank emphasizes stocks with positive revisions to earnings estimates, suggesting that KWR has an improving earnings outlook [3] Group 2: Valuation Metrics - KWR has a forward P/E ratio of 19.57, compared to LIN's forward P/E of 26.08, indicating KWR may be undervalued [5] - KWR's PEG ratio is 1.56, while LIN's PEG ratio is significantly higher at 3.29, suggesting KWR offers better value relative to its expected EPS growth [5] - KWR's P/B ratio is 1.76, whereas LIN's P/B ratio is 4.99, further supporting KWR's valuation advantage [6] Group 3: Value Grades - KWR has a Value grade of A, while LIN has a Value grade of D, indicating that KWR is perceived as a better investment option for value investors [6]

Core Insights - Quaker Houghton has been recognized as one of America's Most Responsible Companies for the third consecutive year, highlighting its commitment to corporate responsibility and sustainability [1][2] Company Overview - Quaker Houghton is the global leader in industrial process fluids, operating in over 25 countries and serving thousands of advanced and specialized companies across various industries including steel, aluminum, automotive, aerospace, and mining [3] - The company employs approximately 4,400 individuals, including chemists, engineers, and industry experts, focusing on delivering high-performing, innovative, and sustainable solutions [3] Recognition and Commitment - The recognition by Newsweek is based on environmental, social, and governance performance indicators derived from sustainability reports and an independent perception survey [1] - The CEO emphasized that this award reflects the company's disciplined approach and the investments made towards achieving meaningful progress in corporate responsibility [2]

Core Insights - The SCCM Small Cap Value Equity Strategy reported a strong performance in Q3 2025, with a gross return of 14.4% and a net return of 14.2%, outperforming the Russell 2000 and Russell 2000 Value indices which returned 12.4% and 12.6% respectively [1] Company Overview - Quaker Chemical Corporation (NYSE:KWR) is recognized as a global leader in industrial process fluids, lubricants, and specialty chemicals, serving various industries including metalworking, steel, automotive, and aerospace [3] - The company has a market capitalization of $2.368 billion, with its stock closing at $136.15 per share on November 24, 2025 [2] Performance Metrics - Quaker Chemical Corporation experienced a one-month return of 2.48%, but its shares have declined by 13.72% over the past 52 weeks [2] Business Model and Strategy - Quaker Houghton has established a resilient business model characterized by high customer retention, strong pricing power, and disciplined execution through economic cycles [3] - The management effectively navigates raw material volatility while expanding margins through operational efficiencies and innovation-driven product differentiation [3] Market Position and Growth Potential - The company's exposure to industrial production, infrastructure investment, and reshoring trends positions it to benefit from a sustained recovery in global manufacturing [3] - Continued penetration in international markets, especially in emerging economies, along with prudent capital allocation and sustainability initiatives, supports durable earnings growth and attractive long-term compounding potential [3] Financial Health - Quaker Houghton boasts a strong balance sheet and solid free cash flow generation, which, combined with expanding strategic partnerships, positions it as a high-quality franchise likely to outperform in the next phase of the economic cycle [3]

Financial Data and Key Metrics Changes - Adjusted EBITDA increased by 5% year-over-year, reaching $83 million, with adjusted earnings per share up 10% to $2.08 [4][15][20] - Net sales for the third quarter were $494 million, a 7% increase from the prior year, driven by a 3% increase in organic volumes and a 5% contribution from acquisitions [15][20] - Gross margins were reported at 36.8%, slightly down from 37.3% in the same quarter last year, but improved sequentially from the second quarter of 2025 [15][16] Business Line Data and Key Metrics Changes - The Asia-Pacific segment showed strong performance with an 18% year-over-year increase in sales, driven by a 3% organic growth and contributions from the Dipsol acquisition [17][18] - The Americas segment saw a 1% increase in net sales year-over-year, but organic volumes were flat due to softer end market activity [18][19] - The AMEA segment experienced a 2% organic sales growth, with double-digit growth in advanced solutions [18] Market Data and Key Metrics Changes - End market activity declined by a low single-digit percentage compared to the prior year, with production levels across major markets down similarly [6][12] - The company outperformed its underlying end markets, achieving a 7% year-over-year increase in sales despite market softness [6][14] Company Strategy and Development Direction - The company is focused on operational discipline and strategic execution, aiming for sustainable long-term growth through innovation and customer service [4][10] - There is a strong emphasis on capital allocation, with a reduction in net leverage to 2.4 times and a commitment to returning cash to shareholders [5][12] - The company is positioning itself to capitalize on growth opportunities in emerging markets, particularly in Asia, with new facilities and R&D capabilities [10][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to deliver growth despite a challenging macroeconomic environment, with expectations for continued momentum driven by share gains and cost actions [12][14] - There is an anticipation of a return to normal seasonal trends in the fourth quarter, with ongoing uncertainty from tariffs and global trade impacting customer operating rates [12][22] - The outlook for 2026 is cautiously optimistic, with expectations for market stabilization and continued share gains [14][41] Other Important Information - The company generated $51 million in operating cash flow during the third quarter, with capital expenditures of approximately $13 million [20][21] - The integration of the Dipsol acquisition is progressing well, contributing positively to the company's performance [7][34] Q&A Session Summary Question: Details on Asia-Pacific business and margin performance - Management highlighted strong growth in Asia-Pacific, with ongoing new business wins and some margin pressures due to raw material costs [27][31] Question: Opportunities in advanced solutions and market share - The company is excited about growth in advanced solutions, particularly with the Dipsol acquisition, and is well-positioned to capture market share [32][34] Question: Q4 outlook and organic growth expectations - Management expressed confidence in Q4 performance, expecting revenue and earnings growth year-over-year, despite normal seasonal impacts [35][38] Question: Customer investment trends and market dynamics - The outlook for 2026 is based on stability in end markets, with expectations for continued share gains rather than significant market growth [41][42] Question: Pricing strategy and share gain sustainability - The company aims to maintain a long-term share gain range of 2% to 4%, with strategic pricing decisions to support this goal [51][52] Question: Exposure to EVs and related market dynamics - The company is growing its presence in the EV market and sees opportunities in both ICE and EV segments [63][64]

Financial Performance - Q3 2025 - Net sales for Q3 2025 were $493.8 million, a 6.8% increase compared to $462.3 million in Q3 2024[12] - Non-GAAP earnings per diluted share for Q3 2025 were $2.08, a 10.1% increase compared to $1.89 in Q3 2024[12] - Adjusted EBITDA for Q3 2025 was $82.9 million, with adjusted EBITDA margins of 16.8%[12, 18] Financial Performance - YTD 2025 - Net sales for YTD 2025 reached $1.42 billion, a 1.8% increase compared to $1.3956 billion in YTD 2024[11, 12] - Non-GAAP earnings per diluted share for YTD 2025 were $5.37[11, 12] - Adjusted EBITDA for YTD 2025 was $227.4 million[11, 12] Leverage and Liquidity - The company's net debt stood at $703 million as of September 30, 2025[23] - The leverage ratio was 2.4x as of September 30, 2025, operating well within the bank's maximum permitted leverage of 4.0x[11, 23] - The company had cash and cash equivalents of $172 million[23] Sales Volume - Sales volumes increased by 3% year-over-year in Q3 2025, driven by new business wins across all regions[15]